Breaking News
Get 50% Off 0
💰 Find healthy stocks that keep paying and growing with ProPicks AI’s new Bharat Dividend Leaders
Get the List

Search Results for "APLS ":

Results: 298

Quotes

APLS Leverage Shares -1x Apple ETP Securities ETF - London etf
Show all (1)

News

Apellis reports SYFOVRE delayed geographic atrophy progression by 1.5 years
By Investing.com

Apellis Pharmaceuticals Inc. (APLS) announced results from a five-year analysis of its GALE extension study showing that SYFOVRE delayed geographic atrophy lesion growth by approximately 1.5 years...

Apellis Pharma earnings beat by $0.15, revenue fell short of estimates
By Investing.com

Investing.com - Apellis Pharma (NASDAQ: APLS) reported second quarter EPS of $-0.33, $0.15 better than the analyst estimate of $-0.48. Revenue for the quarter came in at $178.49M versus the...

Apellis Pharma earnings beat by $0.12, revenue topped estimates
By Investing.com

Investing.com - Apellis Pharma (NASDAQ: APLS) reported third quarter EPS of $1.67, $0.12 better than the analyst estimate of $1.55. Revenue for the quarter came in at $458.6M versus the consensus...

Show all (297)
Results: 1

Refine Results

Instrument Type

Region

 

Country

Exchange

Sector

 

Industry

 
Results: 297

Refine Results

Date

Date
 

Category

Provider

 

News

{{title}}
By {{provider}}

{{content}}

Please try another search

Results: 0

Refine Results

Date

Date
 

Category

Author

Analysis

{{title}}
By {{provider}}

{{content}}

Results: 0

Refine Results

Country

Importance

Economic Events

Results: 0

Tools & Sections

Results: 0

Authors

Continue with Apple
Continue with Google
or
Sign up with Email